Slide 1Evidence synthesis of competing interventions when there is inconsistency in how effectiveness outcomes are measured across studies Nicola Cooper Centre for Biostatistics…

1. Changing Landscape ofHepatitis C Management in 2011:Focus on HIV/HCV Co-InfectionJay Kostman, MD Division of Infectious DiseasesViral Hepatitis Center Perelman School…

1. Projecting ‘Time-to-event’ Outcomes in Technology Assessment: an Alternative Paradigm Adrian Bagust CHE Economic Evaluation seminar 13th February 2014 2. Context …

1. What To Look For in Peregrine’s Q2 Earnings 2. Big Bet on Immunotherapy • Peregrine is developing bavituximab – Phase 3 trial in second-line non-small cell lung…

Ethics and Cluster trials Dr Sarah JL Edwards Senior Lecturer, Research Ethics and Governance Cluster randomized trials are increasingly being used in health and health services…

Slide 1 Statistics for the Terrified: Trial Design and Sample Size Andrea Marshall Mark Williams 1 Learning Objectives By the end of this session you will be aware of The…

6th International Conference on Polyphenols and Health University of Buenos Aires, Argentina 19 October 2013 The Road to Evidence-based Dietary Recommendations for Flavonoids:…

Challenges of systemic therapy in Cholangiocarcinoma Heterogeneous disease Gall bladder cancer Cholangiocarcinoma Intrahepatic cholangiocarcinoma (Peripheral type, mass forming)…

RANDOMISATION, BIAS AND BLINDING IN CLINICAL TRIALS Dipesh Mistry & Jessica Smith September 2010 OVERVIEW Randomisation -What, why, how and when Allocation Concealment…

RANDOMIZED TRIALS Nigel Paneth TYPES OF EXPERIMENTAL STUDIES 1. TRUE EXPERIMENTS -RANDOMIZED TRIALS 2. QUASI-EXPERIMENTS QUASI-EXPERIMENTS a. Cross-sectional comparison:…